Brief Title
Italian Multicenter Database for Open Conversions After EVAR
Official Title
Italian Multicenter Prospective Database for Open Conversions and SemiConversions After Endovascular Aneurysm Repair
Brief Summary
Late endovascular abdominal aneurysm repair (EVAR) complications not amenable to endovascular correction can undergo either late open conversion (LOC) or semi-conversion (SC). LOC is defined as a total or partial endograft explantation >30 days after the initial EVAR. SC is defined as open or laparoscopic surgery for endoleak (EL) correction with complete endograft preservation. The aim of this study is to collect in a prospective database the technical aspects of a multicenter experience of LOC and SC, and to analyse early and long-term outcomes of these two treatments.
Study Type
Observational [Patient Registry]
Primary Outcome
Early Mortality
Secondary Outcome
Early Morbidity
Condition
Abdominal Aortic Aneurysm
Intervention
Open Conversion after EVAR
Study Arms / Comparison Groups
Open Conversions
Description: Patients undergoing total or partial endograft explantation for any EVAR complication.
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
500
Start Date
August 1, 2020
Completion Date
December 31, 2030
Primary Completion Date
December 31, 2029
Eligibility Criteria
Inclusion Criteria: - open or laparoscopic surgery for EVAR complications, with or without endograft explantation Exclusion Criteria: - endovascular reinterventions - extra-anatomical bypass surgery (e.g. femoro-femoral crossover bypass) not associated with direct aorta/endograft surgery
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Paolo Perini, MD, +390521702349, [email protected]
Administrative Informations
NCT ID
NCT04299984
Organization ID
iConveRt
Responsible Party
Principal Investigator
Study Sponsor
Azienda Ospedaliero-Universitaria di Parma
Study Sponsor
Paolo Perini, MD, Principal Investigator, Parma University Hospital
Verification Date
July 2020